8. Quenee LE, Cornelius CA, Ciletti NA, Elli D, Schneewind O (2008) Yersinia pestis caf1 variants and the limits of plague vaccine protection. Infect Immun 76: 2025–2036. 9. Weening EH, Cathelyn JS, Kaufman G, Lawrenz MB, Price P, et al. (2011) The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background. Infect Immun 79: 644–652. 10. Yang X, Hinnebusch BJ, Trunkle T, Bosio CM, Suo Z, et al. (2007) Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol 178: 1059–1067. 11. Perry RD, Fetherston JD (1997) Yersinia pestis–etiologic agent of plague. Clin Microbiol Rev 10: 35–66. 12. Du Y, Rosqvist R, Forsberg A (2002) Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect Immun 70: 1453–1460. 13. Meka-Mechenko TV (2003) F1-negative natural Y. pestis strains. Adv Exp Med Biol 529: 379–381. 14. Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, et al. (2000) Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 283: 2281–2290. 15. Gala´n JE, Nakayama K, Curtiss R, 3rd (1990) Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94: 29–35. 16. Suo Z, Avci R, Deliorman M, Yang X, Pascual DW (2009) Bacteria survive multiple puncturings of their cell walls. Langmuir 25: 4588–4594. 17. Yang X, Suo Z, Thornburg T, Holderness K, Cao L, et al. (2012) Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella. Virulence 3: 29–41. 18. Robinson LS, Ashman EM, Hultgren SJ, Chapman MR (2006) Secretion of curli fibre subunits is mediated by the outer membrane-localized CsgG protein. Mol Microbiol 59: 870–881. 19. Sikora AE, Lybarger SR, Sandkvist M (2007) Compromised outer membrane integrity in Vibrio cholerae Type II secretion mutants. J Bacteriol 189: 8484–8495. 20. Vaara M (2010) Polymyxins and their novel derivatives. Curr Opin Microbiol 13: 574–581. 21. Zhang SS, Park CG, Zhang P, Bartra SS, Plano GV, et al. (2008) Plasminogen activator Pla of Yersinia pestis utilizes murine DEC-205 (CD205) as a receptor to promote dissemination. J Biol Chem 283: 31511–31521. 22. Achtman M, Morelli G, Zhu P, Wirth T, Diehl I, et al. (2004) Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci U S A 101: 17837–17842. 23. Bearden SW, Perry RD (2008) Laboratory maintenance and characterization of Yersinia pestis. Curr Protoc Microbiol Chapter 5: Unit 5B 1. 24. Karasova D, Sebkova A, Vrbas V, Havlickova H, Sisak F, et al. (2009) Comparative analysis of Salmonella enterica serovar Enteritidis mutants with a vaccine potential. Vaccine 27: 5265–5270. 25. Urakawa H, Yamada K, Komagoe K, Ando S, Oku H, et al. (2010) Structure- activity relationships of bacterial outer-membrane permeabilizers based on polymyxin B heptapeptides. Bioorg Med Chem Lett 20: 1771–1775. 26. Soto GE, Hultgren SJ (1999) Bacterial adhesins: common themes and variations in architecture and assembly. J Bacteriol 181: 1059–1071. 27. Soliakov A, Harris JR, Watkinson A, Lakey JH (2010) The structure of Yersinia pestis Caf1 polymer in free and adjuvant bound states. Vaccine 28: 5746–5754. caf Runs as a Double-Edged Sword during Infection 28. Runco LM, Myrczek S, Bliska JB, Thanassi DG (2008) Biogenesis of the fraction 1 capsule and analysis of the ultrastructure of Yersinia pestis. J Bacteriol 190: 3381–3385. 29. Amiel E, Lovewell RR, O’Toole GA, Hogan DA, Berwin B (2010) Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect Immun 78: 2937–2945. 30. Andrews GP, Heath DG, Anderson GW, Jr., Welkos SL, Friedlander AM (1996) Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun 64: 2180–2187. 31. Schmidt G, Amiraian K, Frey H, Stevens RW, Berns DS (1987) Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status. J Clin Microbiol 25: 1993–1998. 32. Pascual DW, Trunkle T, Sura J (2002) Fimbriated Salmonella enterica serovar typhimurium abates initial inflammatory responses by macrophages. Infect Immun 70: 4273–4281. 33. Pujol C, Klein KA, Romanov GA, Palmer LE, Cirota C, et al. (2009) Yersinia pestis can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidification. Infect Immun 77: 2251–2261. 34. Yang X, Thornburg T, Holderness K, Suo Z, Cao L, et al. (2011) Serum antibodies protect against intraperitoneal challenge with enterotoxigenic Escherichia coli. J Biomed Biotechnol 2011: 632396. 35. Prouty AM, Van Velkinburgh JC, Gunn JS (2002) Salmonella enterica serovar typhimurium resistance to bile: identification and characterization of the tolQRA cluster. J Bacteriol 184: 1270–1276. 36. Goto S, Tsuji A, Murai T, Nishida M, Tsukano H, et al. (1995) In vitro activity of twenty-three antimicrobials against Yersinia pestis strains. J infect Chemother 1: 133–134. 37. Anisimov AP, Dentovskaya SV, Titareva GM, Bakhteeva IV, Shaikhutdinova RZ, et al. (2005) Intraspecies and temperature-dependent variations in susceptibility of Yersinia pestis to the bactericidal action of serum and to polymyxin B. Infect Immun 73: 7324–7331. 38. Douglass WC, II (2003) Hydrogen Peroxide: Medical Miracle, Rhino Publishing, S.A.; New Edition edition (June 26, 2003). 19 p. 39. Merritt ME, Donaldson JR (2009) Effect of bile salts on the DNA and membrane integrity of enteric bacteria. J Med Microbiol 58: 1533–1541. 40. Charnetzky WT, Shuford WW (1985) Survival and growth of Yersinia pestis within macrophages and an effect of the loss of the 47-megadalton plasmid on growth in macrophages. Infect Immun 47: 234–241. 41. Ramos-Morales F, Prieto AI, Beuzon CR, Holden DW, Casadesus J (2003) Role for Salmonella enterica enterobacterial common antigen in bile resistance and virulence. J Bacteriol 185: 5328–5332. 42. Walters N, Trunkle T, Sura M, Pascual DW (2005) Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor. Infect Immun 73: 317–324. 43. Perry RD, Pendrak ML, Schuetze P (1990) Identification and cloning of a hemin storage locus involved in the pigmentation phenotype of Yersinia pestis. J Bacteriol 172: 5929–5937. 44. Wu S, Pascual DW, VanCott JL, McGhee JR, Maneval DR, Jr., et al. (1995) Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR. Infect Immun 63: 4933–4938. PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e36283